Mymetics Corp (MYMX)

[Work Harder]

SHIVSF162P3, ARP-6526, contributed by Drs. Janet Harouse, Cecilia Cheng-Mayer, Ranajit Pal and the DAIDS, NIAID; and mAb 2F5 (ARP-1475). Dr. Susan Zolla-Pazner kindly provided mAb 98.6.

Search 8 grants from Janet Harouse

New York Blood Center, New York, NY, United States

https://grantome.com/grant/NIH/U19-HD048957-01-2

NYU

https://www.researchgate.net/profile/Janet-Harouse

Cecilia Cheng-Mayer's research while affiliated with The Rockefeller University and other places

https://www.researchgate.net/scientific-contributions/Cecilia-Cheng-Mayer-2112538815

grants

https://grantome.com/grant/NIH/R01-CA072822-12

Aaron Diamond AIDS Research Center
New York, United States

https://loop.frontiersin.org/people/23209/bio

Ranajit Pal's research while affiliated with Advanced BioScience Laboratories Inc. and other places

https://www.researchgate.net/scientific-contributions/Ranajit-Pal-38758408

Susan Zolla-Pazner

https://en.wikipedia.org/wiki/Susan_Zolla-Pazner#:~:text=In%20the%20early%20days%20of,cells%20of%20HIV%2Dinfected%20individuals.

Zolla-Pazner Laboratory

https://labs.icahn.mssm.edu/zolla-paznerlab/

The Army-led Thai HIV vaccine efficacy trial, known as RV144, tested the “prime-boost” combination of two vaccines:

https://www.hivresearch.org/hiv-research/rv144#:~:text=The%20Army%2Dled%20Thai%20HIV,that%20commonly%20circulate%20in%20Thailand.